![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessHerb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients
-
Article
Open AccessFrequency of bone abnormalities and associated factors in a Spanish cohort of HIV-infected patients
-
Article
Open AccessAbacavir/lamivudine has shown similar efficacy to other nucleoside conventional combinations in previously HIV-infected patients: results at 48 weeks
-
Article
Open AccessSaquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy
-
Article
Open AccessTransient therapy with quadruple NRTI provides immune stability in patients with multidrug resistant HIV-1 and no options for suppressive regimens
-
Article
Open AccessLong-term satisfaction and benefits on quality of life in HIV-infected people after reparatory treatment with Aquamid®for facial Lipoatrophy
-
Article
Open AccessMitochondrial effects of 3 years of CD4-guided HIV treatment interruption
-
Article
Open Access48-week outcomes following switch from AZT/3TC to FTC/TDF (TVD) vs. continuing on AZT/3TC: 48-week interim analysis of the RECOMB trial
-
Article
Effect of Pneumococcal Vaccine on Plasma HIV-1 RNA of Stable Patients Undergoing Effective Highly Active Antiretroviral Therapy
-
Article
Usefulness of the I/D angiotensin-converting enzyme genotype for detecting the risk of left ventricular hypertrophy in pharmacologically treated hypertensive men
The insertion/deletion polymorphism (I/D) of the angiotensin-converting enzyme (ACE) gene has been associated in some studies with a higher prevalence of left ventricular hypertrophy (LVH), but few of them wer...